Mark Christopher Murray - 27 Feb 2026 Form 4 Insider Report for Celanese Corp (CE)

Role: SVP - Acetyls
Signature: /s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray
Issuer symbol: CE
Transactions as of: 27 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 16:19:19 UTC
Previous filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Murray Mark Christopher	SVP - Acetyls	222 W. LAS COLINAS BLVD, STE 900N, IRVING	/s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray	03 Mar 2026	0001800013

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CE	Common Stock	Award	$0	+10,431	+58%	$0.000000	28,279	27 Feb 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CE	Nonqualified Stock Option (right to buy)	Award	$0	+14,561		$0.000000	14,561	27 Feb 2026	Common Stock	14,561	$49.09	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Time-based restricted stock units ("RSUs") granted pursuant to the Company's Amended and Restated 2018 Global Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of Common Stock. The RSUs will vest, subject to continued employment, with respect to 33% of the RSUs on each of February 15, 2027 and February 15, 2028, and with respect to 34% of the RSUs on February 15, 2029.
F2	Time-based employee stock options granted under the Plan.
F3	The options vest and become exercisable, subject to continued employment, in three annual installments of 33%, 33% and 34% beginning February 15, 2027.